NeoStem, Inc. 4
4 · NeoStem, Inc. · Filed Aug 1, 2014
Insider Transaction Report
Form 4
VACZY CATHERINE M
VP and General Counsel
Transactions
- Award
Common Stock, $0.001 par value
2014-08-01+11,756→ 48,397 total - Award
Stock Option (right to purchase)
2014-08-01+25,000→ 25,000 totalExercise: $6.21From: 2014-08-01Exp: 2024-07-31→ Common Stock, par value $0.001 per share (25,000 underlying)
Footnotes (1)
- [F1]On August 1, 2014, the Reporting Person was granted an option (the "Option") to purchase 25,000 shares of the Issuer's common stock (the "Option Shares"), $.001 par value (the "Common Stock"), subject to all terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan (the "Plan"). Also on August 1, 2014, the Reporting Person was granted an award of 11,756 shares of Common Stock (the "Shares"), subject to all of the terms and conditions of the Plan. The Option and Shares were fully vested upon grant and the withholding taxes associated with the Shares are being paid by the Company. The award was approved by the Compensation Committee as a bonus for the successful completion of the acquisition of California Stem Cell, Inc. ("CSC") by the Issuer.